AFN50 injection

BIOLOGICAL2 trials

Sponsors

AlphaNa Bioscience Company Limited, Beijing Boren Hospital

Conditions

Autoimmune DiseasesRelapsed/Refractory Autoimmune Diseases

Early Phase 1

Clinical Study of AFN50 Injection in the Autoimmune Diseases

RecruitingNCT07408336

AlphaNa Bioscience Company LimitedAutoimmune Diseases

Start: 2026-02-04End: 2029-02-03Target: 18Updated: 2026-03-05

A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases

RecruitingNCT07448298

Beijing Boren HospitalRelapsed/Refractory Autoimmune Diseases

Start: 2026-03-09End: 2029-02-28Target: 18Updated: 2026-03-11